Insider filing · ZVRA
Rahsaan Thompson
Chief Legal & Compliance
profile →
Zevra Therapeutics, Inc.
ZVRA · Healthcare · 9 filings in 24 months
ticker →
Rahsaan Thompson sold $475K of Zevra Therapeutics (ZVRA)
Executed Aug 14, disclosed Aug 17, 3 days later.
Value, as filed
$475K
42,666 sh × $11.13
Executed
Aug 14
the trade date, as filed
Disclosed
Aug 17
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RTRahsaan Thompson (Chief Legal & Compliance) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Zevra Therapeutics, Inc. (ZVRA). The largest single filing was $475K of ZVRA (42,666 sh × $11.13, as filed), executed Aug 14.
The name
ZVRAHealthcare · Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United St…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rahsaan Thompson in ZVRA
ZVRASALE
Zevra Therapeutics, Inc.
$438K34,557 sh × $12.68
Exec Jun 22
Filed Jun 23 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. $221K
24,000 sh × $9.21
Exec Jun 26 2025
Filed Jun 30 2025 · 5:30 PM ET